8-year-sustained response in a patient with isolated del(5q) myelodysplastic syndrome undergoing continuous treatment with lenalidomide: a case report
Crossref DOI link: https://doi.org/10.1007/s12254-015-0242-4
Published Online: 2015-12-08
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Farkas, Martin
Text and Data Mining valid from 2015-12-08